Back

Different functions of human scavenger receptors BI and BII overexpressed in a murine abdominal sepsis model

Hayase, N.; Vishnyakova, T. G.; Baranova, I. N.; Bocharov, A. V.; Hu, X.; Patterson, A. P.; Yuen, P. S. T.; Eggerman, T. L.; Star, R. A.

2026-02-07 pathology
10.64898/2026.02.04.703853 bioRxiv
Show abstract

Class B scavenger receptors BI (SR-BI) and BII (SR-BII) internalize lipoproteins but also bind and internalize bacteria. Their roles in sepsis are unknown. We overexpressed human SR-BI and BII in the liver and kidney as well as bone marrow-derived macrophages, and then performed cecal ligation and puncture (CLP) surgery. SR-BI and BII transgenic mice had significantly worse survival compared to WT mice. 24 h after CLP, liver injury markers and histological damage were prominent in both SR-BI and BII transgenic mice, whereas kidney damage was similar. Systemic inflammatory cytokines were markedly increased in SR-BI and BII transgenic mice; parallel increases were seen in liver mRNA expression, not in the kidney. The highest degree of neutrophil infiltration was observed in the liver of SR-BI. Human SR-BI and BII dramatically decreased bacterial accumulation in the liver. Green fluorescence protein-labeled E. coli were efficiently phagocytosed in hepatic macrophages of SR-BI and BII transgenic mice; phagocytosis was more prominent in SR-BII transgenic mice. Finally, human SR-BI overexpression reduced systemic HDL-C level, eliminated adrenal cortex lipid droplets, and dampened the systemic increase of corticosterone after CLP. Supplementation with glucocorticoid and mineralocorticoid improved survival in SR-BI, but not SR-BII, transgenic mice after CLP. In summary, our findings suggest human SR-BI and BII overexpression contributes to higher mortality after CLP by excessive inflammatory response due to adrenal insufficiency (SR-BI) or hyperactive phagocytosis (SR-BII) in the liver.

Matching journals

The top 15 journals account for 50% of the predicted probability mass.

1
Journal of Clinical Investigation
164 papers in training set
Top 0.2%
6.8%
2
eLife
5422 papers in training set
Top 13%
6.3%
3
Critical Care
14 papers in training set
Top 0.1%
6.3%
4
Arteriosclerosis, Thrombosis, and Vascular Biology
65 papers in training set
Top 0.6%
3.9%
5
PLOS ONE
4510 papers in training set
Top 36%
3.9%
6
International Immunopharmacology
15 papers in training set
Top 0.1%
3.6%
7
The American Journal of Pathology
31 papers in training set
Top 0.1%
3.2%
8
PLOS Pathogens
721 papers in training set
Top 4%
3.2%
9
British Journal of Pharmacology
34 papers in training set
Top 0.1%
2.6%
10
Journal of Cellular and Molecular Medicine
18 papers in training set
Top 0.2%
2.6%
11
Metabolism
14 papers in training set
Top 0.1%
1.9%
12
JCI Insight
241 papers in training set
Top 3%
1.9%
13
Journal of Leukocyte Biology
40 papers in training set
Top 0.2%
1.8%
14
Cell Death & Disease
126 papers in training set
Top 1.0%
1.7%
15
International Journal of Molecular Sciences
453 papers in training set
Top 8%
1.7%
50% of probability mass above
16
Scientific Reports
3102 papers in training set
Top 58%
1.7%
17
Disease Models & Mechanisms
119 papers in training set
Top 1%
1.7%
18
Cells
232 papers in training set
Top 3%
1.7%
19
Nature Communications
4913 papers in training set
Top 52%
1.7%
20
Journal of Experimental Medicine
106 papers in training set
Top 2%
1.5%
21
The Journal of Immunology
146 papers in training set
Top 1.0%
1.5%
22
Theranostics
33 papers in training set
Top 0.7%
1.5%
23
The FEBS Journal
78 papers in training set
Top 0.4%
1.3%
24
iScience
1063 papers in training set
Top 22%
1.2%
25
The FASEB Journal
175 papers in training set
Top 2%
1.2%
26
The Journal of Infectious Diseases
182 papers in training set
Top 3%
1.2%
27
Journal of Cellular Physiology
21 papers in training set
Top 0.4%
1.2%
28
Pharmacological Research
15 papers in training set
Top 0.1%
0.9%
29
Frontiers in Immunology
586 papers in training set
Top 7%
0.9%
30
Bioscience Reports
25 papers in training set
Top 1%
0.9%